EICHOR
● Completed
Adjuvant Systemic Treatment for (ER)-Positive HER2-negative Breast Carcinoma in Women Over 70 According to Genomic Grade (GG): Chemotherapy + Endocrine Treatment Versus Endocrine Treatment
Condition: Breast Cancer · Sponsor: UNICANCER
About this study
The purpose of the study is to evaluate the benefit of adjuvant chemotherapy on overall survival for elderly patients with breast cancer, in a sub group with a high risk of relapse according to Genomic Grade test.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (84)
| Clinique du Sud Luxembourg | Arlon, Belgium | — |
| Cliniques universitaires Saint-Luc - UCL | Brussels, Belgium | — |
| Grand Hopital de Charleroi (GHdC) | Charleroi, Belgium | — |
| Hôpital INDC entité Jolimontoise | Haine-Saint-Paul, Belgium | — |
| Centre Hospitalier de l'Ardenne | Libramont, Belgium | — |
| CHC - Les Cliniques Saint-Joseph | Liège, Belgium | — |
| CHU Ambroise Paré | Mons, Belgium | — |
| Clinique et Maternité Sainte-Elisabeth | Namur, Belgium | — |
| Cliniques Saint-Pierre Ottignies | Ottignies, Belgium | — |
| Centre Hôspitalier de Wallonie Picarde (CHWAPI) | Tournai, Belgium | — |
| CHPLT Verviers | Verviers, Belgium | — |
| CHU Mont-Godinne | Yvoir, Belgium | — |
+ 72 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT01564056